Document Detail

New directions in allergic diseases: mechanism-based anti-inflammatory therapies.
MedLine Citation:
PMID:  10887299     Owner:  NLM     Status:  MEDLINE    
Advances in our understanding of allergic inflammation have led to the development of several novel anti-inflammatory drugs that target specific aspects of the inflammatory process. These treatments are based on improvements in existing therapies or on a better understanding of the cellular and molecular mechanisms involved in atopic diseases. Although most attention has been focused on asthma, treatments that inhibit the atopic disease process would have application to all atopic diseases, which often coincide. Specific agents that are now in development for the treatment of allergic inflammation include inhibitors of eosinophilic inflammation (eg, anti-IL-5, CCR3 antagonists, and very late antigen 4 inhibitors), drugs that may inhibit allergen presentation, and inhibitors of T(H)2 cells. More general anti-inflammatory approaches include novel cortico-steroids, phosphodiesterase inhibitors, and mitogen-activated protein kinase inhibitors. Most of the new therapies in development are aimed at inhibiting or suppressing components of the allergic inflammatory response, but in the future, there are possibilities for development of preventive and curative treatments.
P J Barnes
Related Documents :
17989979 - Defining a role for ambient tlr ligand exposures in the genesis and prevention of aller...
11321129 - Prevalence and relationship between allergic diseases and infectious diseases.
16461999 - A specific ccr3 chemokine receptor antagonist inhibits both early and late phase allerg...
8875759 - Onset of graves' thyrotoxicosis after an attack of allergic rhinitis.
11486439 - Nasal inflammation and anti-inflammatory treatment. semantics or clinical reality.
15224629 - Allergic rhinitis: aetiology, predisposing and risk factors.
3983349 - Alexithymia and chronic respiratory disease. a review of current research.
14691999 - Rapid prenatal diagnosis of x-linked chronic granulomatous disease using a denaturing h...
10878819 - Is there a cause-and-effect relationship between alpha-synuclein fibrillization and par...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Journal of allergy and clinical immunology     Volume:  106     ISSN:  0091-6749     ISO Abbreviation:  J. Allergy Clin. Immunol.     Publication Date:  2000 Jul 
Date Detail:
Created Date:  2000-08-09     Completed Date:  2000-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1275002     Medline TA:  J Allergy Clin Immunol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  5-16     Citation Subset:  AIM; IM    
Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Anti-Inflammatory Agents / therapeutic use*
Gene Therapy
Hypersensitivity / drug therapy*,  prevention & control
Immunosuppressive Agents / therapeutic use
Models, Biological
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Anti-Inflammatory Agents; 0/Cytokines; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlo...
Next Document:  Monitoring the patient with asthma: an evidence-based approach.